{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T09:13:32Z","timestamp":1788858812802,"version":"build-2803163510"},"reference-count":60,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Central nervous system (CNS) diseases and disorders have posed a substantial challenge to global health, contributing to disability, mortality, and healthcare costs [...]<\/jats:p>","DOI":"10.3390\/ijms27177941","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:53:28Z","timestamp":1788789208000},"page":"7941","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Special Issue \u201cMolecular Advances in Biomarkers of Central Nervous System Diseases and Disorders\u201d"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-5974","authenticated-orcid":false,"given":"Chiara","family":"Villa","sequence":"first","affiliation":[{"name":"School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9363-1869","authenticated-orcid":false,"given":"David","family":"Gurwitz","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Computational Medicine, Faculty of Health and Medical Sciences, Tel Aviv University, Tel Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: Translating evidence into policy","volume":"19","author":"Feigin","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Siebert, U., Arvandi, M., Boon, P., Bassetti, C.L.A., Berger, T., Moro, E., Montes-Martinez, M., Welter, L., Kruse, C., and Konti, M. (2026). The economic burden of neurological disorders in Europe\u2014COIN-Eu: Study design and analytic framework. Eur. J. Health Econ., Online ahead of print.","DOI":"10.1007\/s10198-026-01965-w"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Baricich, A., Spitoni, G.F., and Morone, G. (2022). Editorial: Long term disability in neurological disease: A rehabilitation perspective. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.964664"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"106808","DOI":"10.1016\/j.neubiorev.2026.106808","article-title":"Global prevalence and disability burden of brain disorders: Impact of neurological, mental, and substance use disorders","volume":"188","author":"Salehinejad","year":"2026","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_5","unstructured":"(2024). Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol., 23, 344\u2013381."},{"key":"ref_6","first-page":"e54337","article-title":"A Comprehensive Review of the Role of Biomarkers in Early Diagnosis of Parkinson\u2019s Disease","volume":"16","author":"Das","year":"2024","journal-title":"Cureus"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: Mapping the road to the clinic","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1021\/acssensors.6c01472","article-title":"From Brain to Blood: Point-of-Care Detection of Biomarkers in Neurological Diseases","volume":"11","author":"Han","year":"2026","journal-title":"ACS Sens."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"38239","DOI":"10.1038\/s41598-025-21983-7","article-title":"Combined multi-omics and brain pathology reveal novel biomarkers for alzheimer\u2019s disease","volume":"15","author":"Zhao","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"103205","DOI":"10.1016\/j.conb.2026.103205","article-title":"Multi-ancestry studies in multi-omics of Alzheimer\u2019s disease: Recent insights and future directions","volume":"99","author":"Shir","year":"2026","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"106759","DOI":"10.1016\/j.ejim.2026.106759","article-title":"Omics medicine: What the clinicians should know","volume":"148","author":"Barbi","year":"2026","journal-title":"Eur. J. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s11033-026-12161-7","article-title":"Multi-omics approaches to parkinsonism: Genomic, proteomic, and non-coding RNA perspectives","volume":"53","author":"Anusha","year":"2026","journal-title":"Mol. Biol. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s11011-026-01873-1","article-title":"Omics-driven strategies for identifying biomarkers in Alzheimer\u2019s disease","volume":"41","author":"Khan","year":"2026","journal-title":"Metab. Brain Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1631\/jzus.B2500789","article-title":"Advances in biomarkers for Parkinson\u2019s disease: From molecular pathology to precision diagnostics","volume":"27","author":"Li","year":"2026","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"121046","DOI":"10.1016\/j.cca.2026.121046","article-title":"Bridging the gaps in Alzheimer\u2019s disease biomarker research: From multi-omics integration to point-of-care diagnostics, a comprehensive review","volume":"589","author":"Khasanov","year":"2026","journal-title":"Clin. Chim. Acta"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13577-026-01368-2","article-title":"Advancing diagnostic biomarkers in Alzheimer\u2019s disease: Interdisciplinary innovations and technological frontiers","volume":"39","author":"Patwekar","year":"2026","journal-title":"Hum. Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"150395","DOI":"10.1016\/j.brainres.2026.150395","article-title":"Fluid-based biomarkers of amyotrophic lateral sclerosis: Recent advances and future prospects","volume":"1888","author":"Jiang","year":"2026","journal-title":"Brain Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1038\/s41467-024-48961-3","article-title":"Plasma proteomics identify biomarkers predicting Parkinson\u2019s disease up to 7 years before symptom onset","volume":"15","author":"Bartl","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00018-022-04614-6","article-title":"Omics-based biomarkers discovery for Alzheimer\u2019s disease","volume":"79","author":"Aerqin","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"ref_21","first-page":"e12374","article-title":"Longitudinal CSF Alzheimer\u2019s disease biomarker changes from middle age to late adulthood","volume":"14","author":"Pettigrew","year":"2022","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1093\/brain\/awac250","article-title":"Preclinical Alzheimer\u2019s disease biomarkers accurately predict cognitive and neuropathological outcomes","volume":"145","author":"Long","year":"2022","journal-title":"Brain"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41591-025-04014-w","article-title":"Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosis","volume":"32","author":"Abdelhak","year":"2026","journal-title":"Nat. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kvetnoy, I., Kheyfets, O., Safaniev, L., Kheifets, V., Mironova, E., Kvetnaia, T., Mazzoccoli, G., Prashchayeu, K., and Gavrilova, A. (2025). Signaling Molecules and Diagnosis of Cognitive Disorders: Current State and Prospects. Int. J. Mol. Sci., 27.","DOI":"10.20944\/preprints202511.0968.v1"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/s43587-025-00951-w","article-title":"Plasma tau biomarkers for biological staging of Alzheimer\u2019s disease","volume":"5","author":"Therriault","year":"2025","journal-title":"Nat. Aging"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"10412","DOI":"10.1038\/s41467-025-66728-2","article-title":"Blood biomarkers of Alzheimer\u2019s disease and progression across different stages of cognitive decline in the community","volume":"16","author":"Valletta","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41586-025-10018-w","article-title":"Biofluid biomarkers in Alzheimer\u2019s disease and other neurodegenerative dementias","volume":"650","author":"Zetterberg","year":"2026","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Chen, R., Fan, S., Di, C., Wu, H., Shi, Z., Liu, F., Lv, Z., Liu, S., and Ji, Y. (2026). Insulin resistance (TyG index) and body mass index as metabolic biomarker combined with ApoE genotype to diagnose Alzheimer\u2019s disease. Front. Aging Neurosci., 18.","DOI":"10.3389\/fnagi.2026.1731547"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Liu, G., Deng, B., Han, X., Zhao, Y., Zeng, S., Yu, S., Wang, L., Wang, S., Wu, Y., and Cai, L. (2026). The complement system in Alzheimer\u2019s disease: Mechanisms, biomarkers, and therapeutic implications. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1798288"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1038\/s41467-026-71448-2","article-title":"Alzheimer\u2019s Disease blood biomarkers measured through remote capillary sampling correlate with cognition in older adults","volume":"17","author":"Corbett","year":"2026","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Qi, J., Li, L., Duan, H., Sun, Y., and Zhang, J. (2026). Integrating neuroimaging and plasma biomarkers to predict preclinical Alzheimer\u2019s disease progression. Front. Neurol., 17.","DOI":"10.3389\/fneur.2026.1801239"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Chen, Y., Zhou, X., Wang, K., Feng, H., Tian, B., Tang, Y., Zhu, X., and Sun, Z. (2026). Association between circulating biomarkers of one-carbon metabolism and glymphatic system function in cognitive decline of Alzheimer\u2019s disease. Front. Neurol., 17.","DOI":"10.3389\/fneur.2026.1779257"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41582-026-01215-w","article-title":"Plasma biomarkers for Alzheimer disease: The road from laboratory results to clinical practice","volume":"22","author":"Teunissen","year":"2026","journal-title":"Nat. Rev. Neurol."},{"key":"ref_34","first-page":"545","article-title":"Circular RNAs outperform established Alzheimer disease biomarkers","volume":"22","author":"Fyfe","year":"2026","journal-title":"Nat. Rev. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Molony, L.E., and Tautz, L. (2026). Phosphatase Signaling as a Therapeutic Strategy in Schizophrenia. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27062822"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Angelopoulou, E., Papatriantafyllou, J., Papageorgiou, S., and Villa, C. (2026). Elucidating the Neurobiological Underpinnings of Mild Behavioral Impairment in Tauopathies: Clinical and Molecular Insights. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27073341"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-5793(00)01676-8","article-title":"Tau aggregation into fibrillar polymers: Taupathies","volume":"476","author":"Avila","year":"2000","journal-title":"FEBS Lett."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Vo, T.N., Shin, H.E., Kim, Y., and Han, I. (2026). Extracellular Vesicle-Based Biomarkers in Spinal Cord Injury: A State-of-the-Art Review on Diagnostic and Prognostic Advances. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27042079"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1007\/s00415-023-12093-3","article-title":"Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: A comprehensive systematic review and diagnostic meta-analysis","volume":"271","author":"Taha","year":"2024","journal-title":"J. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1186\/s12967-026-08562-8","article-title":"Extracellular vesicles as a liquid biopsy for amyotrophic lateral sclerosis: A systematic review and meta-analysis","volume":"24","author":"Bolsinger","year":"2026","journal-title":"J. Transl. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"103178","DOI":"10.1016\/j.arr.2026.103178","article-title":"Extracellular vesicles as paradigm shifters: Transformative roles in diagnosis and therapy for brain disorders","volume":"119","author":"Puthiyattil","year":"2026","journal-title":"Ageing Res. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Phan, N.D., Sharma, R.R., Subramanian, S., and Kartha, R.V. (2026). Extracellular vesicles as minimally invasive biomarkers and therapeutic platforms in rare neurological diseases. Front. Aging, 7.","DOI":"10.3389\/fragi.2026.1813553"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/pharmrev.122.000788","article-title":"Emergence of Extracellular Vesicles as \u201cLiquid Biopsy\u201d for Neurological Disorders: Boom or Bust","volume":"76","author":"Kumar","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40001-023-01606-5","article-title":"Current progression in application of extracellular vesicles in central nervous system diseases","volume":"29","author":"Zhang","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40035-024-00453-6","article-title":"Extracellular vesicles: Biological mechanisms and emerging therapeutic opportunities in neurodegenerative diseases","volume":"13","author":"Wang","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e70323","DOI":"10.1111\/jnc.70323","article-title":"Extracellular Vesicle-Derived microRNAs as Fluid Biomarkers in Neurodegenerative Diseases: A Systematic Review","volume":"170","author":"Zaman","year":"2026","journal-title":"J. Neurochem."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Takata, N., Li, Z., Metlushko, A., Chen, F., Sather, N.A., Lin, X., Schipma, M.J., Carballo-Molina, O.A., Jamroz, C., and Strong, M.E. (2026). Injury and therapy in a human spinal cord organoid. Nat. Biomed. Eng., Online ahead of print.","DOI":"10.1038\/s41551-025-01606-2"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Khan, M., Choi, H., Ahmad, S., Lee, S., Park, J.C., and Han, I. (2026). Emerging Regenerative Medicine for Spinal Cord Injury: Spinal Cord Organoids-on-a-Chip. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27157060"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Mingione, A., Corona, A., Monzani, C., Zollo, A., Cirocco, C., Zaccone, T., Scavone, M., Podda, G.M., Signorelli, P., and Miozzo, M. (2026). Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Differential Biomarkers of Response to Dimethyl Fumarate and Ocrelizumab in Multiple Sclerosis. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27031441"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/13524585221134213","article-title":"Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis","volume":"29","author":"Hegen","year":"2023","journal-title":"Mult. Scler."},{"key":"ref_51","first-page":"2055217315620935","article-title":"Free kappa light chains in cerebrospinal fluid as a biomarker to assess risk conversion to multiple sclerosis","volume":"1","author":"Lucas","year":"2015","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"104573","DOI":"10.1016\/j.ebiom.2023.104573","article-title":"Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity\u2014A cohort study","volume":"91","author":"Hegen","year":"2023","journal-title":"eBioMedicine"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"103535","DOI":"10.1016\/j.msard.2022.103535","article-title":"High or increasing serum NfL is predictive of impending multiple sclerosis relapses","volume":"59","author":"Thebault","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/clinchem\/hvac061","article-title":"An Update on Laboratory-Based Diagnostic Biomarkers for Multiple Sclerosis and Beyond","volume":"68","author":"Saadeh","year":"2022","journal-title":"Clin. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"J\u00e1rd\u00e1nh\u00e1zy, A., Berger, T., Hegen, H., Hemmer, B., Bartosik-Psujek, H., Kes, V.B., Berthele, A., Drulovic, J., Habek, M., and Horakova, D. (2025). Real-World Laboratory Analysis of Molecular Biomarkers in Multiple Sclerosis Centers in Central-Eastern European Countries Covering 107 Million Inhabitants. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202507.1989.v1"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s10038-022-01058-5","article-title":"Molecular genetics of Parkinson\u2019s disease: Contributions and global trends","volume":"68","author":"Funayama","year":"2023","journal-title":"J. Hum. Genet."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Pascual, A., Moulka, T., de F\u00e0bregues, O., Repossi, R., Garc\u00eda-Ruiz, P.J., Ortolano, S., De Lucca, M., Vela-Desojo, L., Alves-Villar, M., and Fr\u00edas, M. (2025). Lysosomal Network Defects in Early-Onset Parkinson\u2019s Disease Patients Carrying Rare Variants in Lysosomal Hydrolytic Enzyme Genes. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26199454"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson\u2019s disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Babkina, A., Ryzhkov, I., Lyubomudrov, M., Yadgarov, M., Tsokolaeva, Z., Boeva, E., and Golubev, A. (2026). Morphological Changes in the Rat Brain in the Early Post-Resuscitation Period: The Relationship Between Hypoxia-Sensitive Immunohistochemical Markers, Hemodynamic and Acid-Base Status. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27146373"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7941\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T09:05:14Z","timestamp":1788858314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,6]]},"references-count":60,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177941"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177941","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,6]]}}}